Resolution of the Cabinet of Ministers "Some Issues of Procurement of Medicinal Products" No. 718 as of September 27th, 2017 postponed the date from which healthcare institutions and facilities that are fully or partially financed from state and local budgets should procure medicinal products in accordance with the National List of Essential Medicines, to January 1st, 2018.
Such a decision was made by the government in order to prevent a shortage of medicines for patients receiving medicines for budgetary funds free of charge and on preferential terms.
Together with this issue, it is necessary to consider the recently adopted and effective Order of the Ministry of Health of Ukraine "On Amendments to Orders of the Ministry of Health of Ukraine No. 84 as of February 11th, 2016 and No. 1050 as of October 7th, 2016" No. 885 as of August 1st, 2017, which amends the Regulation on the National List of Essential Medicines and the Regulation on the Expert Committee on the Selection and Use of Essential Medicines.
The purpose of this regulatory act is to bring the algorithm for introducing changes into the National List in line with the needs of the healthcare system and the calendar plan, which delays the application of the National List.
Now the Expert Committee on the Selection and Use of Essential Medicines is developing a list of drugs to include in the National List by the end of 2017. In accordance with Order of the Ministry of Health of Ukraine No. 558, such selection is carried out taking into account the 20th version of the WHO Model List, the nomenclature of medicines procured for budgetary funds and industry standards. Procurements in 2018 will take place based on such supplemented National List.
In the future, the National List will be supplemented regularly once a year. By July 1st of each year, the advisory body will form the next edition of the National List, submit it to the Ministry of Health of Ukraine, which in turn will submit the draft resolution of the Cabinet of Ministers on introducing the changes to the Government.
"Each application will be considered for up to 180 calendar days, which corresponds to the practice of the WHO and is due to the substantial number of documents that will be submitted to the Expert Committee. Applications will be considered in order of priority of their receipt," - commented Natalia Spivak, the associate.
In addition, the amendments provide that, the Expert Committee may initiate an extraordinary introduction of changes to the National List, if it is necessary, based on the levels of the incidence of the population, the prevalence of diseases and mortality, industry standards in the field of healthcare and / or the nomenclature of medicines procured for budgetary funds.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
